Terminated NCT02435836
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. Over 18 Years
Countries
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00378092
This summary needs review. Please check the official study record and contact the research team for details.
In Bellville Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 17 Years to 47 Years
Countries South Africa
Sponsor Janssen Cilag N.V./S.A.
Condition Schizophrenia Terminated NCT02088060
This study was terminated in Denmark and in Germany. It is testing cannabidiol for Schizophrenia.
Multiple locations, including Glostrup Municipality Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Denmark, Germany
Sponsor Central Institute of Mental Health, Mannheim
Condition Schizophrenia Completed NCT00154258
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 64 Years
Countries
Sponsor Novartis
Condition Schizophrenia Completed NCT00236587
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT02669758
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Bulgaria, Serbia, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01626456
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Bulgaria, Malaysia, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia Terminated NCT01487083
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, France, Austria, ...
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Completed NCT01561898
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 20 Years
Countries
Sponsor Janssen Pharmaceutical K.K.
Condition Schizophrenia Completed NCT01456897
This summary needs review. Please check the official study record and contact the research team for details.
In Kanto Region Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries Japan
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Completed NCT01942148
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Chubu Region Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 17 Years
Countries Japan
Sponsor Otsuka Pharmaceutical Co., Ltd.
Condition Schizophrenia Terminated NCT01129674
This study was terminated in the United States, in Croatia, in Japan, .... It focuses on schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Croatia, Japan, ...
Sponsor Denovo Biopharma LLC
Condition Schizophrenia